Scancell Financial Year End 2025 Results
by chantal | Sep 11, 2025 | Investor Presentations, Investors, Presentations
Recent Posts
- Active Immunotherapy: Ready For Prime Time
- Strategic transactions to unlock longer-term value
- Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
- iSCIB1+ pivotal trial plans advancing
- AACR (American Association for Cancer Research) Annual Meeting, April 2026, San Diego, California
Recent Comments
No comments to show.